MAAS BIOLAB
Maas Biolab is a small neuropharmaceutical company developing a treatment for amyotrophic lateral sclerosis – using cyclosporin as a neuro-protectant drug. Maas Biolab’s patent and related intellectual property rights consist formulation patents and production patents for cyclosporins as neuroprotective agents. More importantly, Maas Biolab has FDA Orphan Drug Designation for cyclosporin to treat ALS.
MAAS BIOLAB
Industry:
Biotechnology Pharmaceutical
Founded:
1997-01-01
Address:
Santa Fe, New Mexico, United States
Country:
United States
Website Url:
http://www.maasbiolab.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
SPF Google Apps For Business Network Solutions DNS Brand Schema Network Solutions Sun ONE Web Server Sun ONE Web Server V6.1
Similar Organizations
CBM Biopharma
CBM Biopharma is a pharmaceutical company.
Official Site Inspections
http://www.maasbiolab.com Semrush global rank: 8.65 M Semrush visits lastest month: 274
- Host name: underconstruction.networksolutions.com
- IP address: 205.178.189.129
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Maas BiolAB"
Maas BiolAB - Crunchbase Company Profile
Maas Biolab is a small neuropharmaceutical company developing a treatment for amyotrophic lateral sclerosis – using cyclosporin as a neuro …See details»
Maas Biolab, LLC - LinkedIn
Maas Biolab is a private neuropharmaceutical company developing a treatment for amyotrophic lateral sclerosis – using cyclosporin as a neuro-protectant drug.See details»
MAASBIOLAB.ORG
Developing Mitogard® intrathecal cyclosporin for amyotrophic lateral sclerosis Learn More. © 2018, Maas Biolab, LLC; all rights reserved.See details»
Maas Biolab 2025 Company Profile: Valuation, Funding
Maas Biolab General Information Description. Operator of a biotechnology firm intended to develop a neuro-pharmaceutical drug. The company's services develop a treatment for …See details»
Maas Biolab LLC - Company Profile and News - Bloomberg Markets
Maas Biolab, LLC operates as a neuropharmaceutical company. The Company develops vaccines for diseases such as chronic neurodegenerative, amyotrophic lateral sclerosis, …See details»
Maas Biolab, LLC - Company Profile & Staff Directory - ContactOut
Maas Biolab is a private neuropharmaceutical company developing a treatment for amyotrophic lateral sclerosis – using cyclosporin as a neuro-protectant drug. Maas Biolab’s patent and …See details»
Maas BiolAB LLC Information | CareersInPharmaceutical.com
Maas BiolAB LLC is located at Albuquerque, NM and is a neuropharmaceutical company developing a treatment- the use of cyclosporins as neuro-protectants- for chronic …See details»
Maas Biolab LLC:Company Profile & Technical …
Maas Biolab LLC is a company that provides Amyotrophic lateral sclerosis, Medicine, Cyclosporins and more. Maas Biolab LLC is headquartered in United States New Mexico. …See details»
Maas Biolab - Products, Competitors, Financials, Employees ...
Maas Biolab is a private neuropharmaceutical company developing treatments for amyotrophic lateral sclerosis (ALS). Use the CB Insights Platform to explore Maas Biolab's full profile. Maas …See details»
Maas Biolab LLC - Company Contact Details | Seamless.AI
Maas Biolab is a private neuropharmaceutical company developing a treatment for amyotrophic lateral sclerosis – using cyclosporin as a neuro-protectant drug. ... Industry Pharmacists …See details»
Maas Biolab, LLC Overview | SignalHire Company Profile
Maas Biolab is a private neuropharmaceutical company developing a treatment for amyotrophic lateral sclerosis – using cyclosporin as a neuro-protectant drug. ... Organization Website: …See details»
MAAS BIOLAB, INC. - Golden
MAAS BIOLAB, INC. is an Albuquerque, New Mexico-based company. Overview Structured Data Issues Contributors Activity. ContentsSee details»
Maas BiolAB - Profiles & Contacts - Crunchbase
Maas Biolab is a small neuropharmaceutical company . Founded 1997 Private Santa Fe, New Mexico, United States 1-10 maasbiolab.com/ . BiotechnologySee details»
MAAS Biolab - 2025 Company Profile - Tracxn
May 5, 2025 MAAS Biolab - US-based, early-stage biopharma developing cyclosporin as a neuroprotective in Neurodegenerative diseases, starting with ALS. This company is not active …See details»
MAAS BIOLAB, INC. - VentureRadar
MAAS BIOLAB, INC. VentureRadar profile. Find out more about MAAS BIOLAB, INC. including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Maas Biolab LLC - BioCentury Company Profiles - BCIQ
Apr 5, 2010 Maas Biolab LLC - BioCentury Company Profiles for the biopharma industrySee details»
Firm | SBIR
Intrathecal Cyclosporin for the Treatment of Amyotrophic Lateral Sclerosis (ALS) Amount: $2,084,619 DESCRIPTION (provided by applicant): The scientific research proposed, the …See details»
Company Information - RocketReach
Maas Biolab is a private neuropharmaceutical company developing a treatment for amyotrophic lateral sclerosis – using cyclosporin as a neuro-protectant drug. Maas Biolab’s patent and …See details»
Maas Biolab, LLC overview - services, products, equipment data …
Learn about Maas Biolab, LLC - locations, products, equipment, revenue, and target industries. Read the latest news, find similar companies and employees, and moreSee details»
Maas Biolab, LLC profiles | FinalScout | FinalScout
Maas Biolab is a private neuropharmaceutical company developing a treatment for amyotrophic lateral sclerosis – using cyclosporin as a neuro-protectant drug. Maas Biolab's patent and …See details»